Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: Data from the Romanian Acute Heart Failure Syndromes registry

Journal of Cardiovascular Medicine

Volumn 17, Issue 2, 2016, Pages 92-104

  Chioncel, Ovidiu ^a   Ambrosy, Andrew P ^b   Bubenek, Serban ^a   Filipescu, Daniela ^a   Vinereanu, Dragos ^a   Petris, Antoniu ^c   Christodorescu, Ruxandra ^d   Macarie, Cezar ^a   Gheorghiade, Mihai ^e   Collins, Sean P ^f  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e NORTHWESTERN UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY   (United States)

Author keywords

In hospital therapies; Outcomes; Pulmonary edema

Indexed keywords

FUROSEMIDE; GLYCERYL TRINITRATE; INOTROPIC AGENT; NATRIURETIC FACTOR; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; BREATHING RATE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CONTINUOUS INFUSION; DISEASE REGISTRY; ELEVATED BLOOD PRESSURE; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; LUNG CONGESTION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TACHYPNEA; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; CLINICAL TRIAL; COMPLICATION; HEART FAILURE; LENGTH OF STAY; MIDDLE AGED; MULTICENTER STUDY; PULMONARY EDEMA; REGISTER; ROMANIA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PULMONARY EDEMA; REGISTRIES; ROMANIA;

EID: 84953360414     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000192     Document Type: Article

References (23)

1. Adams KF J.r., Fonarow GC, Emerman C.L., et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149:209-216.
2. Parissis JT, Nikolaou M, Mebazaa A., et al. Acute pulmonary oedema: clinical characteristics, prognostic factors, and in-hospital management. Eur J Heart Fail 2010; 12:1193-1202.
3. Logeart D, Isnard R, Resche-Rigon M, on behalf of the working group on Heart Failure of the French Society of Cardiology. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail 2013; 15:465-476.
4. Collins SP, Pang PS, Lindsell J, et al International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes. Eur J Heart Fail 2010; 12:1253-1260.
5. Oliva F, Mortara A, Cacciatore G., et al., on the behalf of the IN-HF Outcome Investigators. Acute heart failure patient profiles, management and inhospital outcome: results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail 2012; 14:1208-1217.
6. Sato N, Kajimoto K, Keida T., et al. ATTEND Investigators. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). Circ J 2013; 77:944-951.
7. Nieminen MS, Brutsaert D, Dickstein K., et al., on behalf of the Euro Heart Survey Investigators. Euro Heart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006; 27:2725-2736.
8. Zannad F, Mebazaa A, Juilliere Y. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006; 8:697-705.
9. Spinar J, Parenica J, Vitovec J., et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care 2011; 15:R291.
10. Maggioni AP, Dahlström U, Filippatos G., et al., on behalf of the Heart Failure Association of the ESC (HFA). EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2010; 12:1076-1084.
11. Chioncel O, Vinereanu D, Datcu M, et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) Registry. Am Heart J 2011; 162:142-153.
12. Clark AL, Cleland JG Causes and treatment of oedema in patients with heart failure. Nat Rev Cardiol 2013; 10:156-170.
13. Dickstein K, Cohen-Solal A, Filippatos G., et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29:2388-2442.
14. Margulescu AD, Rimbas RC, Florescu M, et al Cardiac adaptation in acute hypertensive pulmonary edema. Am J Cardiol 2012; 109:1472-1481.
15. Teerlink JR, Cotter G, Davison B.A., et al., for the RELAXin in Acute Heart Failure (RELAX-AHF) Investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013; 381:29-39.
16. Gheorghiade M, Greene SJ, Ponikowski P, et al Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction. Eur J Heart Fail 2013; 15:679-689.
17. Gheorghiade M, Blair JE, Filippatos G.S., et al. HORIZON-HF Investigators. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol 2008; 51:2276-2285.
18. Gray A, Goodacre S, Newby D.E., et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008; 359: 142-151.
19. Voors AA, Dittrich HC, Massie B.M., et al. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol 2011; 57:1899-1907.
20. Tabrizi F, Englund A, Rosenqvist M., et al. Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J 2007; 28:2449-2455.
21. Baldasseroni S, Opasich C, Gorini M., et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002; 143:398-405.
22. Kass DA, Chen C-H, Curry C, et al Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999; 99:1567-1573.
23. Leclercq C, Kass DA Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39:194-201.